M&A Deal Summary |
|
---|---|
Date | 2010-07-06 |
Target | LightLab Imaging |
Sector | Medical Products |
Buyer(s) | St. Jude Medical |
Deal Type | Add-on Acquisition |
Deal Value | 90M USD |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 1976 |
Sector | Medical Products |
Employees | 18,000 |
Revenue | 5.5B USD (2016) |
St. Jude Medical, Inc. is a medical device manufacturer dedicated to transforming the treatment of most expensive, epidemic diseases. St. Jude Medical five major areas of focus that include heart failure, atrial fibrillation, neuromodulation, traditional cardiac rhythm management and cardiovascular. St. Jude Medical was formed in 1976 and is based in St. Paul, Minnesota.
DEAL STATS | # |
---|---|
Overall | 11 of 18 |
Sector (Medical Products) | 11 of 17 |
Type (Add-on Acquisition) | 11 of 17 |
State (Massachusetts) | 1 of 2 |
Country (United States) | 9 of 15 |
Year (2010) | 1 of 3 |
Size (of disclosed) | 13 of 14 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2008-12-22 |
MediGuide
Haifa, Israel MediGuide (Delaware, USA & Haifa, Israel) - an Israeli based company (originally spun off from Elbit Systems - NASDAQ: ESLT and got its first investment from Vitalife VC during 2001), is the provider of technology, solutions and applications for intra body navigation and less invasive procedures with a special focus on cardiology. Based on its proprietary gMPS technology, MediGuide brings the ability to navigate gMPS Enabled Devices (catheters, wires and other devices equipped with a sub millimeter gMPS sensor) in the MPS Ready Cathlab environment, co-developed by MediGuide in collaboration with the leading imaging companies. |
Buy | $138M |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2010-09-07 |
CardioMEMS
Atlanta, Georgia, United States CardioMEMS is a provider of medical devices focused on the application of MicroElectroMechanical Systems (MEMS) technology to create innovative, implantable devices for the diagnosis and management of chronic diseases. The Company markets the EndoSure Wireless Sensor for monitoring aortic aneurysms and is developing a similar implantable device for monitoring congestive heart failure. CardioMEMS was founded in 2000 and is based in Atlanta, Georgia. |
Buy | - |